Recurrent giant fibrovascualr oesophageal polyp: Benefits and pitfalls of a multimodal approach()

Fibrovascular polyp of the cervical esophagus represents about 0.5% to 1% of all benign oesophageal tumours. Usually asymptomatic, when FP protrudes into the oesophageal lumen, this may cause respiratory obstruction and provoke dysphagia, vomiting, dyspnoea, and retrosternal pain. In this article, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Quijano, Yolanda, Ferri, Valentina, Duran, Hipolito, Diaz, Eduardo, Fabra, Isabel, Malave, Luis, Ruiz, Pablo, de Nobili, Giovanni, Caruso, Riccardo, Vicente, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163960/
https://www.ncbi.nlm.nih.gov/pubmed/34023549
http://dx.doi.org/10.1016/j.ijscr.2021.105935
_version_ 1783701012555497472
author Quijano, Yolanda
Ferri, Valentina
Duran, Hipolito
Diaz, Eduardo
Fabra, Isabel
Malave, Luis
Ruiz, Pablo
de Nobili, Giovanni
Caruso, Riccardo
Vicente, Emilio
author_facet Quijano, Yolanda
Ferri, Valentina
Duran, Hipolito
Diaz, Eduardo
Fabra, Isabel
Malave, Luis
Ruiz, Pablo
de Nobili, Giovanni
Caruso, Riccardo
Vicente, Emilio
author_sort Quijano, Yolanda
collection PubMed
description Fibrovascular polyp of the cervical esophagus represents about 0.5% to 1% of all benign oesophageal tumours. Usually asymptomatic, when FP protrudes into the oesophageal lumen, this may cause respiratory obstruction and provoke dysphagia, vomiting, dyspnoea, and retrosternal pain. In this article, we describe a multimodal approach in the treatment of a complex recurrent FP, for which surgical resection represents the safer and less invasive procedure.
format Online
Article
Text
id pubmed-8163960
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81639602021-06-05 Recurrent giant fibrovascualr oesophageal polyp: Benefits and pitfalls of a multimodal approach() Quijano, Yolanda Ferri, Valentina Duran, Hipolito Diaz, Eduardo Fabra, Isabel Malave, Luis Ruiz, Pablo de Nobili, Giovanni Caruso, Riccardo Vicente, Emilio Int J Surg Case Rep Case Report Fibrovascular polyp of the cervical esophagus represents about 0.5% to 1% of all benign oesophageal tumours. Usually asymptomatic, when FP protrudes into the oesophageal lumen, this may cause respiratory obstruction and provoke dysphagia, vomiting, dyspnoea, and retrosternal pain. In this article, we describe a multimodal approach in the treatment of a complex recurrent FP, for which surgical resection represents the safer and less invasive procedure. Elsevier 2021-05-04 /pmc/articles/PMC8163960/ /pubmed/34023549 http://dx.doi.org/10.1016/j.ijscr.2021.105935 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Quijano, Yolanda
Ferri, Valentina
Duran, Hipolito
Diaz, Eduardo
Fabra, Isabel
Malave, Luis
Ruiz, Pablo
de Nobili, Giovanni
Caruso, Riccardo
Vicente, Emilio
Recurrent giant fibrovascualr oesophageal polyp: Benefits and pitfalls of a multimodal approach()
title Recurrent giant fibrovascualr oesophageal polyp: Benefits and pitfalls of a multimodal approach()
title_full Recurrent giant fibrovascualr oesophageal polyp: Benefits and pitfalls of a multimodal approach()
title_fullStr Recurrent giant fibrovascualr oesophageal polyp: Benefits and pitfalls of a multimodal approach()
title_full_unstemmed Recurrent giant fibrovascualr oesophageal polyp: Benefits and pitfalls of a multimodal approach()
title_short Recurrent giant fibrovascualr oesophageal polyp: Benefits and pitfalls of a multimodal approach()
title_sort recurrent giant fibrovascualr oesophageal polyp: benefits and pitfalls of a multimodal approach()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163960/
https://www.ncbi.nlm.nih.gov/pubmed/34023549
http://dx.doi.org/10.1016/j.ijscr.2021.105935
work_keys_str_mv AT quijanoyolanda recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach
AT ferrivalentina recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach
AT duranhipolito recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach
AT diazeduardo recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach
AT fabraisabel recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach
AT malaveluis recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach
AT ruizpablo recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach
AT denobiligiovanni recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach
AT carusoriccardo recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach
AT vicenteemilio recurrentgiantfibrovascualroesophagealpolypbenefitsandpitfallsofamultimodalapproach

Ejemplares similares